Related Experiment Video
Updated: Mar 11, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
Nrf2 Activation as a Protective Feedback to Limit Cell Death in High Glucose-Exposed Cardiomyocytes
Cheng-Yen Tsai1,2, Su-Ying Wen3,4, Shi-Yann Cheng5,6,7
1Department of Pediatrics, China Medical University Beigang Hospital, Yunlin 651, Taiwan,ROC.
Abstract:
Hyperglycemia leads to excess reactive oxygen species (ROS) generation, which causes many diabetic complications, such as cardiomyopathy. Nuclear factor erythroid 2-related factor 2 (Nrf2), a redox-sensing transcription factor, can up-regulate its downstream antioxidant gene expressions in response to oxidative stress. However, the regulatory signal pathway in which high glucose (HG) induces Nrf2 activation is still unclear. Our results demonstrated that HG (33 mM) can indeed stimulate Nrf2 protein expression and translocation into the nucleus in cardiomyocytes, enhancing the downstream antioxidant protein levels. Using siRNAs, p38, JNK, PKCα, and PKCδ, as well as ROS scavengers, it was observed that the dependence of PKCα/PKCδ on ROS production to enhance JNK and p38 phosphorylation mediated HG-induced cardiac Nrf2 expression and activation. Knockdown of Nrf2 by siRNA transfection increased cleaved-caspase3, reduced Bcl2 in the cellular protein level and further exacerbated HG-induced apoptosis. In addition, all of these proteins induced by HG in vitro were also increased in STZ-induced diabetic rat ventricles in vivo. Our study demonstrated that HG-induced cardiac Nrf2 activation occurs through PKCα/PKCδ-ROS-JNK/p38 signaling. These findings may provide a therapeutic target to counteract the oxidative stress associated with diabetic cardiomyopathy. J. Cell. Biochem. 118: 1659-1669, 2017. © 2016 Wiley Periodicals, Inc.
Insights
High glucose activates the antioxidant Nrf2 pathway in heart cells via PKC and ROS signaling, protecting against diabetic cardiomyopathy. This pathway involves ROS, JNK, and p38, offering a potential therapeutic target.
Area of Science:
- Cardiovascular Biology
- Molecular Cell Biology
- Endocrinology
Background:
- Hyperglycemia causes oxidative stress and diabetic cardiomyopathy.
- Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key antioxidant transcription factor.
- The signaling pathway linking high glucose to Nrf2 activation in cardiomyocytes is not fully understood.
Purpose of the Study:
- To elucidate the signaling pathway regulating high glucose-induced Nrf2 activation in cardiomyocytes.
- To investigate the role of protein kinase C (PKC) and reactive oxygen species (ROS) in this process.
- To assess the protective effect of Nrf2 against high glucose-induced apoptosis in cardiac cells.
Main Methods:
- Utilized high glucose (HG) treatment in cultured cardiomyocytes and streptozotocin (STZ)-induced diabetic rat models.
- Employed small interfering RNAs (siRNAs) to knockdown specific proteins (p38, JNK, PKCα, PKCδ, Nrf2).
- Assessed protein expression levels (Nrf2, cleaved-caspase3, Bcl2) and cellular events like apoptosis and nuclear translocation.
Main Results:
- High glucose (33 mM) increased Nrf2 protein expression and nuclear translocation in cardiomyocytes.
- PKCα/PKCδ activation, dependent on ROS production, mediated HG-induced JNK and p38 phosphorylation, leading to Nrf2 activation.
- Nrf2 knockdown exacerbated HG-induced apoptosis, evidenced by increased cleaved-caspase3 and decreased Bcl2.
- These signaling events were mirrored in the ventricles of STZ-induced diabetic rats.
Conclusions:
- High glucose-induced cardiac Nrf2 activation is regulated by the PKCα/PKCδ-ROS-JNK/p38 signaling cascade.
- Nrf2 activation plays a protective role against high glucose-induced oxidative stress and apoptosis in cardiomyocytes.
- Targeting this pathway could offer a therapeutic strategy for diabetic cardiomyopathy.
More Related Videos
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Regulation of the Unfolded Protein Response
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Extrinsic Apoptotic Pathway

